We are live on
!
Find out more
RI
RTW Investments Portfolio holdings
AUM
$10B
1-Year Est. Return
135.35%
This Fund
S&P 500
This Quarter
Est. Return
+2.84%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$293M
AUM Growth
+$17.2M
(+6.3%)
Cap. Flow
+$24.2M
Cap. Flow
% of AUM
8.27%
Top 10 Holdings %
Top 10 Hldgs %
72.5%
Holding
39
New
5
Increased
13
Reduced
10
Closed
4
Top Buys
| 1 |
BLUE
bluebird bio
BLUE
|
+$16.9M |
| 2 |
SPDR Gold Trust
GLD
|
+$9.99M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$7.07M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$5.76M |
| 5 |
VIVE
VIVEVE MED INC
VIVE
|
+$3.8M |
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
+$7.93M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$4.74M |
| 3 |
Omeros
OMER
|
+$4.49M |
| 4 |
KITE
Kite Pharma, Inc.
KITE
|
+$2.85M |
| 5 |
Lipocine
LPCN
|
+$2.44M |
Sector Composition
| 1 | Healthcare | 81.44% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alnylam Pharmaceuticals
ALNY
$37.7B
| $46.2M | 15.78% |
832,549
-33,830
| -4% | -$2.13M |
|
2
Incyte
INCY
$23.2B
| $31.4M | 10.72% |
392,236
+12,821
| +3% | +$995K |
|
|
BLUE
3
DELISTED
bluebird bio
BLUE
| $26.5M | 9.05% |
47,248
+29,772
| +170% | +$16.9M |
|
|
ACHN
4
DELISTED
Achillion Pharmaceuticals
ACHN
| $18.9M | 6.46% |
2,424,136
-134,723
| -5% | -$1.16M |
|
|
LJPC
5
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $18.8M | 6.43% |
1,176,146
+7,081
| +0.6% | +$127K |
|
|
AVXS
6
DELISTED
AveXis, Inc. Common Stock
AVXS
| $18.1M | 6.19% |
476,367
+2,993
| +0.6% | +$101K |
|
|
7
Bristol-Myers Squibb
BMY
$123B
| $15.4M | 5.27% |
209,701
+100,000
| +91% | +$7.07M |
|
|
KITE
8
DELISTED
Kite Pharma, Inc.
KITE
| $14.3M | 4.88% |
285,518
-57,985
| -17% | -$2.85M |
|
|
SSRG
9
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $12.1M | 4.14% |
922,215
+2,535
| +0.3% | +$30.6K |
|
|
10
SPDR Gold Trust
GLD
$129B
| $10.5M | 3.59% |
+83,000
| New | +$9.99M |
|
11
Atara Biotherapeutics
ATRA
$75.8M
| $10.5M | 3.58% |
18,635
-290
| -2% | -$139K |
|
|
AGEN
12
Agenus
AGEN
$204M
| $9.84M | 3.36% |
123,765
+745
| +0.6% | +$58.1K |
|
13
BioCryst Pharmaceuticals
BCRX
$2.33B
| $6.35M | 2.17% |
2,237,066
+263,134
| +13% | +$817K |
|
14
iShares 20+ Year Treasury Bond ETF
TLT
$41.9B
| $6.25M | 2.14% |
45,000
+15,000
| +50% | +$1.98M |
|
|
DRNA
15
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $6.08M | 2.08% |
2,026,894
| – | – |
|
|
ICPT
16
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.64M | 1.93% |
+39,500
| New | +$5.76M |
|
17
Celldex Therapeutics
CLDX
$2.78B
| $5.55M | 1.9% |
84,282
+18,324
| +28% | +$1.16M |
|
|
18
Omeros
OMER
$669M
| $5.54M | 1.89% |
526,788
-364,734
| -41% | -$4.49M |
|
|
VIVE
19
DELISTED
VIVEVE MED INC
VIVE
| $3.34M | 1.14% |
+815
| New | +$3.8M |
|
|
JO
20
DELISTED
iPath Bloomberg Coffee Subindex Total Return ETN due June 24, 2038
JO
| $3.19M | 1.09% |
+144,200
| New | +$2.82M |
|
|
CORI
21
DELISTED
Corium International, Inc.
CORI
| $2.96M | 1.01% |
852,961
+24,629
| +3% | +$100K |
|
|
IVTY
22
DELISTED
Invuity, Inc
IVTY
| $2.15M | 0.74% |
226,042
+13,234
| +6% | +$91.9K |
|
23
Regenxbio
RGNX
$580M
| $1.94M | 0.66% |
242,784
+1,461
| +0.6% | +$16.2K |
|
|
FPRX
24
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.85M | 0.63% |
44,701
-182,297
| -80% | -$7.93M |
|
|
GBT
25
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.61M | 0.55% |
97,138
-93,843
| -49% | -$1.89M |
|
Similar funds
BEI
MG
LWCFA
HRCM
RA
VNIM
OAM
GI